mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
9e-05 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.07 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.3 |